Fenestra Launch

wmic-2

Fenestra Launch

MediLumine’s Fenestra® imaging agents for preclinical computed tomography will be presented at the upcoming WMIC.

Fenestra® LC and Fenestra® VC imaging agents are used for a wide array of applications in preclinical computed tomography and molecular imaging. These hepatocyte selective nanoemulsions help to enable co-registration of soft tissue CT data for multimodal molecular imaging, quantification of metastatic tumor burdens, 4D imaging for characterization of murine cardiovascular disease and quantitative assessments of anti-angiogenic therapies.

Come see us (booth #319) at the upcoming WMIC!

Share This Post

More To Explore

Enhancing Cardiac Repair with ENPP1 Inhibition

A recent study offers insights into a novel approach to cardiac repair by inhibiting ENPP1, an enzyme critical to regulating extracellular nucleotide metabolism. MediLumine’s Fenestra

Managed by Carbon Digital